Antifungal and anti-biofilm effects of hydrazone derivatives on Candida spp
Pierre Popczyk, Alina Ghinet, Clovis Bortolus, Laure Kamus, Marc F Lensink, Jérôme de Ruyck, Boualem Sendid, Faustine Dubar · 2024
Read Antifungal and anti-biofilm effects of hydrazone derivatives on Candida spp by Pierre Popczyk, Alina Ghinet, Clovis Bortolus, Laure Kamus, Marc F Lensink, Jérôme de Ruyck, Boualem Sendid, Faustine Dubar (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11600518.txt.
Description
Invasive Candida infections are growing harder to treat as resistance spreads and naturally resistant species appear. Pierre Popczyk and co-authors look for new antifungal drugs in 2024. Their starting point is an enzyme the yeast needs to build trehalose, a sugar that helps it survive heat, drying, and other stresses inside the human body. Guided by the enzyme's three-dimensional shape, they designed a family of compounds built on a hydrazone scaffold.
The new derivatives fought Candida species in the lab and also attacked biofilms, the protective mats the yeast forms on surfaces. Just as important, the compounds showed no toxicity in cell tests or in wax moth larvae, a stand-in animal model. The authors present the family as a promising starting point for antifungal drugs that hit both free yeast and its biofilm form.
Catalog record
| CREATOR | Pierre Popczyk, Alina Ghinet, Clovis Bortolus, Laure Kamus, Marc F Lensink, Jérôme de Ruyck, Boualem Sendid, Faustine Dubar |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |